ESR2 and cancer: Besides the synergistic effects on the proliferation behavior, co-treatment increased the expression of the vitamin D receptor (VDR) and ERβ and influenced the cellular metabolism by decreasing extracellular acidification (which is a measure of glycolytic flux in cancer cells) as well as cell respiration rates (a measure of mitochondrial respiration) [165].